Aging Well, Sleeping Efficiently: Protecting Health In Later Life

AGEWISE Project 4: PROTECTING HEALTH IN LATER LIFE

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00177385

Acronym

AgeWise

Enrollment

Registered

2005-09-15

Start date

2003-06-30

Completion date

2011-09-30

Last updated

2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Promotion, Sleep

Keywords

Sleep, Sleep Hygiene, Modest sleep deprivation, Healthy Aging and sleep, Health Promotion

Brief summary

The purpose of this study is to see whether protecting sleep quality in later life is important in continued healthy aging. The value of education in healthy sleep practices along with reducing time in bed each night by going to bed 30 minutes later, and of healthy dietary practices will be tested for their effects on sleep quality, health, and well being.

Detailed description

The goal of this project is to test the efficacy of restricting time in bed and education in healthy sleep practices for maintaining or even enhancing sleep consolidation and depth in subjects aged 75+ who are at risk for decay in sleep quality and daytime well being; to determine the associated benefits for health; and to examine the persistence of such effects for 12 months beyond the end of the 18-month intervention. This project focuses not on pathology but on prevention of sleep decay and preservation of sleep in individuals who have already evidenced successful aging.

Interventions

BEHAVIORALModest sleep deprivation with sleep hygiene education

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

75 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* age 75 or older * without sleep disorders * without psychiatric disorders * Folstein MMSE of 24 or greater

Exclusion criteria

* Apnea-hypopnea index greater than 30 * Mean sleep latency less than 6 * Psychotropic medications present

Design outcomes

Primary

Measure	Time frame
Polysomnographic measures of sleep consolidation, sleep depth and daytime sleepiness at baseline, 6mos.,12mos., 18mos.,30 mons.	—

Secondary

Measure	Time frame
Clinical measures of sleep quality, general functioning, mental health at baseline,6 mos., 12 mons., 18mons.,30mons.	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026